Coexpression cluster:C273

Full id: C273_Neutrophils_CD14_Eosinophils_Monocytederived_CD4_Natural_Mast

Phase1 CAGE Peaks

Hg19::chr10:121154442..121154449,-	p@chr10:121154442..121154449 -
Hg19::chr11:47377641..47377656,-	p@chr11:47377641..47377656 -
Hg19::chr11:47377786..47377798,-	p@chr11:47377786..47377798 -
Hg19::chr11:47378636..47378650,-	p@chr11:47378636..47378650 -
Hg19::chr11:47379735..47379747,-	p@chr11:47379735..47379747 -
Hg19::chr11:47379860..47379874,-	p@chr11:47379860..47379874 -
Hg19::chr14:35871286..35871297,-	p@chr14:35871286..35871297 -
Hg19::chr15:58447767..58447778,+	p@chr15:58447767..58447778 +
Hg19::chr15:86212972..86212989,+	p20@AKAP13
Hg19::chr16:31926161..31926175,+	p@chr16:31926161..31926175 +
Hg19::chr17:21194520..21194548,+	p7@MAP2K3
Hg19::chr19:47993823..47993862,-	p@chr19:47993823..47993862 -
Hg19::chr1:183556727..183556731,-	p@chr1:183556727..183556731 -
Hg19::chr1:27947499..27947502,-	p@chr1:27947499..27947502 -
Hg19::chr1:27951156..27951162,-	p@chr1:27951156..27951162 -
Hg19::chr1:27951294..27951312,-	p@chr1:27951294..27951312 -
Hg19::chr1:27951368..27951397,-	p@chr1:27951368..27951397 -
Hg19::chr1:27951398..27951454,-	p@chr1:27951398..27951454 -
Hg19::chr1:27955714..27955719,-	p@chr1:27955714..27955719 -
Hg19::chr1:33424609..33424645,-	p@chr1:33424609..33424645 -
Hg19::chr1:89589346..89589358,-	p@chr1:89589346..89589358 -
Hg19::chr20:48500628..48500646,+	p@chr20:48500628..48500646 +
Hg19::chr22:35738610..35738623,+	p@chr22:35738610..35738623 +
Hg19::chr22:35738627..35738686,+	p@chr22:35738627..35738686 +
Hg19::chr22:35738688..35738740,+	p@chr22:35738688..35738740 +
Hg19::chr22:35738813..35738828,+	p@chr22:35738813..35738828 +
Hg19::chr22:35738894..35738925,+	p@chr22:35738894..35738925 +
Hg19::chr22:35738945..35738954,+	p@chr22:35738945..35738954 +
Hg19::chr22:35738968..35738980,+	p@chr22:35738968..35738980 +
Hg19::chr22:35739061..35739082,+	p@chr22:35739061..35739082 +
Hg19::chr22:35739086..35739098,+	p@chr22:35739086..35739098 +
Hg19::chr22:35739277..35739390,+	p@chr22:35739277..35739390 +
Hg19::chr22:35739411..35739459,+	p@chr22:35739411..35739459 +
Hg19::chr22:35739472..35739491,+	p@chr22:35739472..35739491 +
Hg19::chr22:35739601..35739650,+	p@chr22:35739601..35739650 +
Hg19::chr22:35739658..35739678,+	p@chr22:35739658..35739678 +
Hg19::chr22:35739706..35739737,+	p4@TOM1
Hg19::chr22:35739742..35739814,+	p2@TOM1
Hg19::chr22:35739816..35739887,+	p3@TOM1
Hg19::chr2:114700995..114701006,+	p@chr2:114700995..114701006 +
Hg19::chr2:145240683..145240706,-	p@chr2:145240683..145240706 -
Hg19::chr2:145246478..145246502,-	p@chr2:145246478..145246502 -
Hg19::chr2:28619598..28619640,+	p@chr2:28619598..28619640 +
Hg19::chr5:169716803..169716815,-	p@chr5:169716803..169716815 -
Hg19::chr6:13316777..13316781,-	p@chr6:13316777..13316781 -
Hg19::chr7:130586359..130586363,-	p@chr7:130586359..130586363 -
Hg19::chr8:59473361..59473383,+	p@chr8:59473361..59473383 +

Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

---

No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data

---

GO ID	GO name	FDR corrected p-value
GO:0004691	cAMP-dependent protein kinase activity	0.0302731887304975
GO:0004708	MAP kinase kinase activity	0.0302731887304975
GO:0004712	protein serine/threonine/tyrosine kinase activity	0.0302731887304975
GO:0004690	cyclic nucleotide-dependent protein kinase activity	0.0302731887304975
GO:0004674	protein serine/threonine kinase activity	0.0302731887304975

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>

---

Cell Type

Ontology term	p-value	n
myeloid leukocyte	5.81e-53	72
defensive cell	2.51e-52	48
phagocyte	2.51e-52	48
classical monocyte	4.13e-52	42
CD14-positive, CD16-negative classical monocyte	4.13e-52	42
leukocyte	5.29e-46	136
granulocyte monocyte progenitor cell	2.11e-44	67
myeloid lineage restricted progenitor cell	1.79e-43	66
monopoietic cell	1.88e-41	59
monocyte	1.88e-41	59
monoblast	1.88e-41	59
promonocyte	1.88e-41	59
macrophage dendritic cell progenitor	2.18e-41	61
myeloid cell	7.55e-38	108
common myeloid progenitor	7.55e-38	108
hematopoietic stem cell	4.99e-37	168
angioblastic mesenchymal cell	4.99e-37	168
hematopoietic lineage restricted progenitor cell	1.20e-36	120
nongranular leukocyte	4.57e-36	115
hematopoietic oligopotent progenitor cell	5.14e-36	161
hematopoietic multipotent progenitor cell	5.14e-36	161
hematopoietic cell	1.20e-33	177
stuff accumulating cell	5.62e-21	87
intermediate monocyte	5.14e-11	9
CD14-positive, CD16-positive monocyte	5.14e-11	9
granulocyte	1.56e-08	8
mesenchymal cell	2.05e-08	354
connective tissue cell	8.55e-08	361

Uber Anatomy

Ontology term	p-value	n
hematopoietic system	1.18e-41	98
blood island	1.18e-41	98
bone marrow	2.17e-38	76
hemolymphoid system	8.81e-37	108
bone element	1.00e-36	82
immune system	1.35e-33	93
skeletal element	1.13e-31	90
skeletal system	1.09e-27	100
lateral plate mesoderm	2.15e-14	203
adult organism	6.01e-12	114
musculoskeletal system	5.60e-10	167
connective tissue	2.57e-07	371
neural tube	4.38e-07	56
neural rod	4.38e-07	56
future spinal cord	4.38e-07	56
neural keel	4.38e-07	56

Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

---

Novel motifs

JASPAR motifs

Motifs	-log10(p-value)
{{{tfbs_overrepresentation_jaspar}}}

ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data

---

No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data

---